Patents by Inventor Junko Matsuo

Junko Matsuo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AGENT FOR IMPROVING BRAIN FUNCTION AND AGENT FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT
    Publication number: 20200108040
    Abstract: An agent for improving brain function and agent for preventing or treating cognitive impairment, which comprises: 5 to 50 parts by weight of a protein; 5 to 80 parts by weight of a medium-chain fatty acid triglyceride as a lipid; and 1 to 50 parts by weight of a carbohydrate, per 100 parts by weight.
    Type: Application
    Filed: December 5, 2019
    Publication date: April 9, 2020
    Applicants: THE FOOD SCIENCE INSTITUTE FOUNDATION, NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
    Inventors: Hiroshi KUNUGI, Miho OTA, Junko MATSUO, Yoshitatsu ICHIHARA
  • AGENT FOR IMPROVING BRAIN FUNCTION AND AGENT FOR PREVENTING OR TREATING COGNITIVE IMPAIRMENT
    Publication number: 20180169052
    Abstract: An agent for improving brain function and agent for preventing or treating cognitive impairment, which comprises: 5 to 50 parts by weight of a protein; 5 to 80 parts by weight of a medium-chain fatty acid triglyceride as a lipid; and 1 to 50 parts by weight of a carbohydrate, per 100 parts by weight.
    Type: Application
    Filed: July 23, 2015
    Publication date: June 21, 2018
    Applicants: THE FOOD SCIENCE INSTITUTE FOUNDATION, NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
    Inventors: Hiroshi KUNUGI, Miho OTA, Junko MATSUO, Yoshitatsu ICHIHARA
  • Location reporting method and related mobile communication terminal
    Patent number: 7558584
    Abstract: Menu data supplied from an IP server 500 to a mobile station 101 is embedded with a location information substitution data string “NULLAREA” together with a URL of a particular IP server 500. The mobile station 101, upon detection of the location information substitution data string from a menu data selected by the user, determines whether location information can be transmitted to the IP server 500. In the case where the determination is that the transmission is permitted, the mobile station 101 detects its location information and, after substituting the location information for the location information substitution data string, transmits the data to the IP server 500.
    Type: Grant
    Filed: March 30, 2001
    Date of Patent: July 7, 2009
    Assignee: NTT DoCoMo, Inc.
    Inventors: Hiroyuki Yamamoto, Masaaki Maeda, Koichi Takahara, Masahiro Kaiwa, Yoichi Tanibayashi, Kaoru Nakajima, Junko Matsuo, Kazunori Kosuge, Katsutoshi Murata
  • Location reporting method and related mobile communication terminal
    Publication number: 20020138650
    Abstract: Menu data supplied from an IP server 500 to a mobile station 101 is embedded with a location information substitution data string “NULLAREA” together with a URL of a particular IP server 500. The mobile station 101, upon detection of the location information substitution data string from a menu data selected by the user, determines whether location information can be transmitted to the IP server 500. In the case where the determination is that the transmission is permitted, the mobile station 101 detects its location information and, after substituting the location information for the location information substitution data string, transmits the data to the IP server 500.
    Type: Application
    Filed: November 28, 2001
    Publication date: September 26, 2002
    Inventors: Hiroyuki Yamamoto, Masaaki Maeda, Koichi Takahara, Masahiro Kaiwa, Yoichi Tanibayashi, Kaoru Nakajima, Junko Matsuo, Kazunori Kosuge, Katsutoshi Murata
  • Nicorandil-containing preparation for injection
    Patent number: 4769381
    Abstract: A non-liquid type preparation for injection that has improved stability contains N-(2-hydroxyethyl)-nicotinamide nitrate ester (generally known as nicorandil) and an inorganic or organic acid and/or an alkaline metal salt thereof. These ingredients, together with an excipient that is pharmaceutically acceptable, may be dissolved in a solvent, sterilized by filtration and freeze-dried to obtain a freeze-dried preparation, or may be dissolved in a solvent under an aseptic condition and recrystallized to obtain an injectable powder. Nicorandil preparations according to the present invention are very stable and useful in clinical applications.
    Type: Grant
    Filed: January 13, 1987
    Date of Patent: September 6, 1988
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Kouji Ishihara, Mika Sanada, Naoki Matsuo, Yoshimitsu Iida, Yoshinori Matsuoka, Junko Matsuo